Babson Diagnostics Partners with Orchard Software to Provide Innovative BetterWay Blood Testing Service
Txylo.com/10288427

CARMEL, Ind., Sept. 26, 2024 ~ In a recent press release, Orchard Software announced its partnership with Babson Diagnostics, a leading-edge laboratory service based in Austin, Texas. This collaboration aims to revolutionize blood testing and make it more accessible and convenient for patients.

Babson Diagnostics is the creator of BetterWay™ blood testing, which has been hailed as a significant advancement in the medical field. This innovative service not only provides a patient-preferred experience but also enables high-quality testing in more convenient settings.

The partnership between Babson and Orchard Software was first established in 2019 with the goal of reimagining blood testing. With rapid growth in mind, Babson implemented Orchard® Enterprise Lab™, a flexible and configurable laboratory information system (LIS). This system allows for customization of workflow tasks to suit different laboratory setups, making it a perfect fit for Babson's unique workflow.

According to Dr. Eric Olson, founder and chief operating officer of Babson Diagnostics, "The LIS platform offers the flexibility and innovation needed to enable a radically new way of blood testing." This sentiment is echoed by Billie Whitehurst, CEO of Orchard Software, who stated that they are proud to collaborate with innovative partners like Babson Diagnostics to improve access and patient care.

More on Txylo.com

• AI Visibility: The Key to Beating Google's AI Overviews and Regaining Traffic
• Stuck Doing Math or Figuring Out Life's Numbers? Calculator.now Makes It Stupidly Simple
• Colbert Packaging Announces WBENC Recognition
• Ragin' Tails Seafood Co. Will Donate Grand Opening Tip Proceeds to Texas Flood Relief Efforts
• Texas: Governor Abbott Announces $10,000 Reward For Individual Connected To ICE Facility Ambush

One of the key developments in this partnership is the creation of a capillary blood collection device called the BD MiniDraw™ Capillary Blood Collection System. Developed in collaboration with Becton, Dickinson and Company (BD), this device uses only one tenth of the amount of blood typically collected in a venous draw. It has been cleared by the FDA and is now being used by Babson to offer an evidence-based alternative to traditional laboratory collection methods.

Babson's goal is to inspire people to seek necessary medical care by providing a better experience at accessible locations such as pharmacies. Samples collected at these locations are then sent to BetterWay's centralized laboratory for testing using traditional laboratory analyzers. Orchard's solutions play a crucial role in this process by providing sample tracking and rapid results reporting.

In conclusion, the partnership between Babson Diagnostics and Orchard Software is a testament to the power of collaboration and innovation in the medical field. With their combined efforts, they are making significant strides towards improving access to high-quality blood testing for patients.

---

Show All News | Report Violation